Sugi Predict

Sugi Predict / Compounds / SCHEMBL6730668

SCHEMBL6730668

SCHEMBL6730668

CS(=O)(=O)c1ccc(-c2nc(C(F)F)[nH]c2-c2cc(F)cc(F)c2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 5/20 0.40
▸ PTGS2 P35354 5/20 0.40
▸ MAPK14 Q16539 5/20 0.39
▸ CYP3A4 P08684 4/20 0.39
▸ ALOX5 P09917 3/20 0.39
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ CSNK1D P48730 1/20 0.37
▸ CSNK1E P49674 1/20 0.37
▸ MAPK11 Q15759 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CSNK1A1L Q8N752 1/20 0.37
▸ TYK2 P29597 2/20 0.36
▸ KIT P10721 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ EPAS1 Q99814 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723200 0.93 PTGS1 (0.48) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6723515 0.91 ALOX5 (0.40) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6729827 0.91 PIK3CD (0.38) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6719062 0.91 PTGS2 (0.38) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6722081 0.89 ALDH1A1 (0.47) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6723552 0.89 PTGS1 (0.39) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6718410 0.89 PIK3CD (0.39) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6723415 0.89 ALDH1A1 (0.43) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6721907 0.88 PTGS2 (0.46) PTGS1PTGS2MAPK14CYP3A4ALOX5
SCHEMBL6721674 0.88 PTGS1 (0.39) PTGS1PTGS2MAPK14CYP3A4ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 — — US disclosed
EP-1296971-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2003-04-02 — — EP disclosed
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2002-12-05 — — US disclosed
WO-2001081332-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2001-11-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, FPR1, PTGES2 PTGS1 4/4885PTGS2 5/4885MAPK14 2499/4885
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 PTGS1 4/4885PTGS2 5/4885MAPK14 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.